Dante Labs: Mark Van Oene
Dante Labs has named Mark Van Oene to its board of directors. Van Oene is chief operating officer of Pacific Biosciences, a newly created position he took in January. He joined PacBio after 15 years at Illumina, where he most recently served as senior VP and chief commercial officer, in charge of worldwide sales and service. Before working at Illumina, Van Oene was director of genotyping services at Ellipsis Biotherapeutics.